Saja Abo Thyab: How MDS Can Progress to AML
Saja Abo Thyabb, Medical Laboratory Science Student, shared a post on LinkedIn:
“Inside the bone marrow, blood cells are constantly being produced in a highly organized process.
But when genetic mutations disrupt this balance, serious hematological disorders can begin to develop.
Myelodysplastic Syndrome (MDS) represents ineffective and abnormal blood cell production inside the marrow.
Over time, these abnormal cells may accumulate additional mutations and progress into Acute Myeloid Leukemia (AML), a highly aggressive disease characterized by uncontrolled proliferation of immature blast cells.
On the other hand, Chronic Myeloid Leukemia (CML) develops through a different molecular mechanism involving the Philadelphia chromosome and BCR-ABL fusion gene, leading to uncontrolled myeloid cell proliferation.
Although AML, CML, and MDS differ in pathogenesis and progression, they remain interconnected through the disruption of normal hematopoiesis within the bone marrow.
What makes hematology remarkable is that microscopic cellular changes and molecular abnormalities can reveal the entire story of disease progression long before it becomes clinically apparent.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients